Dolby Laboratories (DLB) Aktienübersicht
Dolby Laboratories, Inc. beschäftigt sich mit der Entwicklung und Herstellung von Audio-, Bildgebungs-, Zugangs- und anderen Hardware- und Softwarelösungen für die Fernseh-, Rundfunk- und Live-Entertainment-Industrie in den Vereinigten Staaten und international. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 1/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 5/6 |
DLB Community Fair Values
Create NarrativeSee what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Dolby Laboratories, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$49.80 |
| 52-Wochen-Hoch | US$77.00 |
| 52-Wochen-Tief | US$48.66 |
| Beta | 0.81 |
| 1 Monat Veränderung | -5.84% |
| 3 Monate Veränderung | -17.84% |
| 1 Jahr Veränderung | -33.75% |
| 3 Jahre Veränderung | -44.28% |
| 5 Jahre Veränderung | -48.95% |
| Veränderung seit IPO | 104.94% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jul 03
DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.Analyseartikel • Jun 20
Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low
Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...
Narrativ-Update • Jun 18
DLB: World Cup Streaming Deal Will Support Future Share Price Recovery
Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.Narrativ-Update • Jun 04
DLB: Immersive Content Partnerships Will Support Future Share Price Recovery
Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.Recent updates
Narrativ-Update • Jul 03
DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.Analyseartikel • Jun 20
Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low
Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...Narrativ-Update • Jun 18
DLB: World Cup Streaming Deal Will Support Future Share Price Recovery
Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.Narrativ-Update • Jun 04
DLB: Immersive Content Partnerships Will Support Future Share Price Recovery
Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.Narrativ-Update • May 17
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).Seeking Alpha • May 03
Dolby: I Don't Mind Waiting In 2026
Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking AlphaNarrativ-Update • May 01
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Narrativ-Update • Apr 17
DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside
Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.Narrativ-Update • Apr 03
DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook
Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).Narrativ-Update • Mar 19
DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook
Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.Narrativ-Update • Mar 05
DLB: Media Partnerships And Buybacks Will Support Measured Future Returns
Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Narrativ-Update • Feb 19
DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns
Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.Narrativ-Update • Feb 04
DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions
Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.Analyseartikel • Feb 02
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...Narrativ-Update • Jan 21
DLB: Technology Adoption And Solid Execution Will Support Future Share Gains
Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.Narrativ-Update • Jan 06
DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption
Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.Analyseartikel • Jan 05
Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?
Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...Narrativ-Update • Dec 21
DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption
Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.Narrativ-Update • Dec 07
DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds
Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.Narrativ-Update • Nov 23
DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds
Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.Analyseartikel • Nov 11
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • Sep 27
Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...Narrativ-Update • Sep 06
Expanding Auto And Device Ecosystems Will Define Immersive Entertainment
Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.Analyseartikel • Jul 28
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...Analyseartikel • May 27
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate
Key Insights Dolby Laboratories' estimated fair value is US$112 based on 2 Stage Free Cash Flow to Equity Dolby...Analyseartikel • May 06
Should You Be Adding Dolby Laboratories (NYSE:DLB) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analyseartikel • Apr 07
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it received a lot of...Analyseartikel • Mar 23
Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Could Signal Some Risk
Dolby Laboratories, Inc.'s ( NYSE:DLB ) price-to-earnings (or "P/E") ratio of 29.6x might make it look like a strong...Analyseartikel • Mar 10
Return Trends At Dolby Laboratories (NYSE:DLB) Aren't Appealing
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...Seeking Alpha • Feb 07
Dolby Laboratories Remains Fully Valued On Slow Growth
Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking AlphaAnalyseartikel • Feb 01
Dolby Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Dolby Laboratories, Inc. ( NYSE:DLB ) just released its latest first-quarter results and things are looking bullish...Analyseartikel • Jan 26
Are Investors Undervaluing Dolby Laboratories, Inc. (NYSE:DLB) By 38%?
Key Insights The projected fair value for Dolby Laboratories is US$128 based on 2 Stage Free Cash Flow to Equity Dolby...Aktionärsrenditen
| DLB | US Software | US Markt | |
|---|---|---|---|
| 7D | -2.6% | -1.2% | 0.7% |
| 1Y | -33.8% | -20.5% | 20.6% |
Rendite im Vergleich zur Industrie: DLB unter dem Niveau der Branche US Software , die im vergangenen Jahr eine Rendite von -20.5% erzielte.
Rendite vs. Markt: DLB hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 20.6 erzielte.
Preisvolatilität
| DLB volatility | |
|---|---|
| DLB Average Weekly Movement | 4.4% |
| Software Industry Average Movement | 10.1% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: DLB hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: DLBDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1965 | 2,051 | Kevin Yeaman | www.dolby.com |
Dolby Laboratories, Inc. beschäftigt sich mit der Entwicklung und Herstellung von Audio-, Bildgebungs-, Zugangs- und anderen Hardware- und Softwarelösungen für die Fernseh-, Rundfunk- und Live-Entertainment-Industrie in den Vereinigten Staaten und international. Das Unternehmen entwickelt und lizenziert seine Audiotechnologien wie AAC, HE-AAC und erweitertes HE-AAC, eine digitale Audiocodec-Lösung; AVC, ein digitaler Videocodec, der in STBs, mobilen Geräten, Kameras, Fernsehdiensten und anderen Produkten verwendet wird; und Dolby Atmos und Dolby Vision umfassen Codierungstechnologien, die von Künstlern verwendet werden, um fesselndere und immersivere Audio- und Videoerlebnisse zu schaffen. Das Unternehmen bietet auch DD+, eine fortschrittliche Surround-Sound-Audio-Codec-Technologie, Dolby AC-4, einen Audio-Codec, der modernste Komprimierung verwendet, und HEVC, einen digitalen Video-Codec, der Videos komprimiert.
Dolby Laboratories, Inc.'s Grundlagenzusammenfassung
| DLB grundlegende Statistiken | |
|---|---|
| Marktanteil | US$4.74b |
| Gewinn(TTM) | US$243.65m |
| Umsatz(TTM) | US$1.36b |
19.3x
Kurs-Gewinn-Verhältnis 3.5x
Kurs-Umsatz-VerhältnisIst DLB zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| DLB Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$1.36b |
| Kosten der Einnahmen | US$171.46m |
| Bruttogewinn | US$1.19b |
| Sonstige Ausgaben | US$949.80m |
| Gewinn | US$243.65m |
Zuletzt gemeldete Gewinne
Mar 27, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 2.58 |
| Bruttomarge | 87.44% |
| Nettogewinnspanne | 17.85% |
| Schulden/Eigenkapital-Verhältnis | 0% |
Wie hat sich DLB auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
2.9%
Aktuelle Dividendenrendite55%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/10 23:47 |
| Aktienkurs zum Tagesende | 2026/07/10 00:00 |
| Gewinne | 2026/03/27 |
| Jährliche Einnahmen | 2025/09/26 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Dolby Laboratories, Inc. wird von 13 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Vikram Kesavabhotla | Baird |
| Patrick Sholl | Barrington Research Associates, Inc. |
| Eric Wold | B. Riley Securities, Inc. |